TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Q: What does CUSIP 89854M101 represent in this 13F holders report?

CUSIP 89854M101 is the security identifier for TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in Q2 2022?

23 institutional investors reported TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 89854M101

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Voting Common Stock, par value $0.0001 per share
Shares outstanding: 52,382,313
Total 13F shares: 9,682,082
Share change: +275,060
Total reported value: $30,449,817
Price per share: $3.14
Number of holders: 23
Value change: +$1,528,632
Number of buys: 12
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 89854M101?
CUSIP 89854M101 identifies TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 89854M101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Christoph H. Westphal	3/4/5	10%+ Owner	— class O/S missing	2,193,472	$10,898,266	—	20 Jul 2021	3/4/5
BlackRock Finance, Inc.	13F	Company	2.9%	1,519,188	$4,254,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	2.7%	1,425,000	$3,990,000	—	31 Mar 2022	13F
Deer Management Co. LLC	13F	Company	2.4%	1,245,505	$3,487,000	—	31 Mar 2022	13F
Alphabet Inc.	13F	Company	2.1%	1,077,080	$3,016,000	—	31 Mar 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2%	1,021,764	$2,861,000	—	31 Mar 2022	13F
HHLR ADVISORS, LTD.	13F	Company	1.3%	669,513	$1,875,000	—	31 Mar 2022	13F
DC Funds, LP	13F	Company	1.2%	630,000	$1,764,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1%	550,000	$1,540,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	0.43%	226,929	$636,000	—	31 Mar 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.38%	200,000	$560,000	—	31 Mar 2022	13F
Tekla Capital Management LLC	13F	Company	0.38%	200,000	$560,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.3%	158,944	$445,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	0.26%	136,930	$383,000	—	31 Mar 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	115,000	$322,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.11%	60,000	$168,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.07%	39,076	$110,000	—	31 Mar 2022	13F
DC Investments Management, LLC	13F	Company	0.07%	35,563	$100,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	33,159	$92,000	—	31 Mar 2022	13F
Marquette Asset Management, LLC	13F	Company	0.06%	28,895	$81,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	13,300	$37,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.02%	12,600	$35,000	—	31 Mar 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	7,799	$22,000	—	31 Mar 2022	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,000	$3,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0%	361	$1,000	—	31 Mar 2022	13F
Ittai Harel	3/4/5	Director	— class O/S missing	9,146	—	—	01 Jun 2022	3/4/5

Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q2 2022

As of 30 Jun 2022, TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,682,082 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., Deer Management Co. LLC, Alphabet Inc., TANG CAPITAL MANAGEMENT LLC, DC Funds, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Newtyn Management, LLC, VANGUARD GROUP INC, and Tekla Capital Management LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-1

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.